10-K/A XBRL

FORM 10-K/A

Company: Entrada Therapeutics, Inc.
Filed: August 8, 2023
Period of Report: December 31, 2022
Accession Number: 0001104659-23-088597

View Document ↗ View on SEC.gov ↗